Cargando empresa
Just reported
Q3 2026 results
From National Healthcare's results release of 6 de noviembre de 2026; its quarterly report has since been filed.
Revenue
Actual
408M US$
+6,6 % y/y
0,0 % q/qGuided
—
No guide given
EPS, GAAP
Actual
0,85 US$
-66 % y/y
-67 % q/qGuided
—
No guide given
EPS, adjusted: 1,76 US$
Operating income, GAAP
Actual
40,6M US$
+34 % y/y
-17 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes National Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.22,8B US$A+
EHCEncompass Health Corporation13,8B US$A+
ENSGEnsign Group, Inc.11B US$A
PACSPACS Group, Inc.7,7B US$A
CONConcentra Group Holdings Parent, Inc.5,4B US$A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 oct 2026CAGraded C, now A
Estados financieros completos →
Construido a partir de los propios informes de National Healthcare Corp. ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.
